#news #biotech Bristol Myers Squibb’s deucravacitinib flunks midphase IBD trial, raising questions about potential blockbuster

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bristol Myers Squibb’s deucravacitinib flunks midphase IBD trial, raising questions about potential blockbuster .Bristol Myers Squibb’s deucravacitinib flunks midphase IBD trial, raising questions about potential blockbuster
ntaylor
Thu, 10/07/2021 – 08:09

from FierceBiotech: Biotech https://ift.tt/3DluxPO